期刊文献+

老年肥厚型心肌病与高血压左室肥厚患者临床特点的比较 被引量:8

Comparison of clinical characteristics between hypertrophic cardiomyopathy patients and hypertension patients with left ventricular hypertrophy in the elderly
原文传递
导出
摘要 目的分析老年肥厚型心肌病与老年高血压左室肥厚患者的临床特点。方法回顾性分析老年肥厚型心肌病患者(35例)与老年高血压左室肥厚患者(35例)的症状和体征及心电图、超声心动图的差异。结果老年肥厚型心肌病患者均无高血压史。两组年龄、性别、脑血管病史及肥厚型心肌病家族史比较,差异均无统计学意义(均为P〉0.05)。老年肥厚型心肌病患者中,晕厥者5例(14.3%),高血压左室肥厚患者中,无晕厥者,2组比较,差异有统计学意义(P〈0.05)。老年肥厚型心肌病患者中无心脏杂音者9例(25.7%),明显少于高血压左室肥厚患者[23例(65.7%),P〈0.05]。心电图示:老年肥厚型心肌病患者中,有异常Q波者10例(28.6%),较高血压左室肥厚患者的1例(2.9%)多(P〈0.05)。老年肥厚型心肌病患者中心房颤动(房颤)及STT改变者分别为11例(31.4%)及34例(97.1%),明显多于高血压左室肥厚患者的3例(8.6%)及26例(74.3%),均为P〈0.05。超声心动图示:老年肥厚型心肌病患者的左室后壁厚度为(9.5±1.1)mm,明显薄于高血压左室肥厚患者的(12.6±1.0)mm(P〈0.01),左房内径老年肥厚型心肌病患者为(41.6±6.3)mm,高血压左室肥厚患者为(38.6±5.5)mm,两组差异有统计学意义(P〈0.05);老年肥厚型心肌病患者二尖瓣血流频谱E/A〈1者15例(42.9%),明显少于高血压左室肥厚患者的32例(91.4%),P〈0.05。老年肥厚型心肌病患者有主动脉瓣钙化者7例(20.0%),高血压左室肥厚患者20例(57.1%),二者差异有统计学意义(P〈0.05),室间隔厚度、左室内径与射血分数2组相似(均为P〉0.05)。结论老年肥厚型心肌病患者临床表现有晕厥者多,心脏有明显的杂音,心电图有异常Q波及房颤者较多,超声心动图显示左室不对称性肥厚多;高血压左室肥厚患者左室肥厚多为对称性,合并主动脉瓣钙化者多。 Objective To investigate the clinical and echocardiographic features between hypertrophic cardiomyopathy patients (HCM group) and hypertension patients with left ventricular hypertrophy (H-LVH group) in the elderly. Methods In all the patients aged 60 years and over, the clinical characteristics, electrocardiographic and echocardiographic records in 35 patients with hypertrophic cardiomyopathy (no hypertension history), 35 patients with hypertension and left ventricular hypertrophy were retrospectively analyzed. Results (1) A higher incidence of syncope was found in group HCM (14.3%) compared with group H-LVH(0%) ,P〈0.05. In group H-LVH, there were more patients without cardiac murmurs than in group HCM(65. 7% vs. 25. 7%, P〈0. 05) . No significant differences existed in symptoms, signs and cardiac function class between group H-LVH and group HCM(all P)0.05). (2) In ECG, higher incidences of atrial fibrillation, abnormal Q waves and no-specific ST-T changes were found in group HCM compared with group H-LVH (31.4% vs. 8. 6%, 28.6% vs. 2. 9%, 97. 1% vs. 74.3% respectively; all P〈O. 05 respectively). (3) In comparison of group HCM versus group H-LVH, left ventricular posterior wall (LVPW) thickness was thinner [(9.5±1.1) vs. (12.6±1.0)mm], the frequency of E/A〈1 was lower (42.9% vs. 91.4%) left atrium dimension was bigger[(41.6±6.3) mm vs. (38.6±5.5)mm],the frequency of calcified aortic valves was lower(20.0 % vs. 57.1 %). No significant differences in mitral annular calcification and EF values were found between group H-LVH and group HCM(P〉0.05 respectively). Conclusions More HCM patients in the elderly have syncope symptom, heart murmur and abnormal Q wave in ECG compared with hypertension patients with left ventricular hypertrophy. Left ventricle of HCM patients is dissymmetrical, while left ventricle of hypertension patients is symmetrical, and has more calcific aortic valves.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2007年第11期840-843,共4页 Chinese Journal of Geriatrics
基金 1999年人事部D类项目(bj-1999-538)
关键词 肥厚型心肌病 高血压 Hypertrophic cardiomyopathy Hypertension
  • 相关文献

参考文献9

  • 1Hiroyuki M, Martin G, Larson SC, et al. Single-gene mutations and increased left ventricular wall thickness in the community the Framingham heart study. Circulation, 2006,113 : 2697-2705.
  • 2Peter A, Wolfram G, Anna V, et al. Heart rate variability in patients with cardiac hypertrophy-relation to left ventricular mass and etiology. Am Heart J, 2006,151 : 829-836.
  • 3Sherrrid MV, Mahenthiran JO, Casteneda V, et al. Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy. Am J Cardiol, 2006, 97: 106-112.
  • 4Topoi EJ, Traill TA, Fortuin NJ, Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med, 1985,312:277-283.
  • 5Akasaka T, Yoshikawa J, Yoshida K, et al . Phasic coronary flow characteristics in patients with hypertrophic cardiomyopathy: a study by coronary Doppler catheter. J Am Soc Echocardiogr , 1994, 7: 9- 19.
  • 6Kenny A, Wisbey CR, Shapiro LM. Measurement of left anterior descending coronary artery flow velocities by transthoracic Doppler ultrasound. Am J Cardiol , 1994,73: 1021-1022.
  • 7张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 8Agatston AS, Polakoff R, Hippogoankar R, et al. The significance of increased left ventricularout flow treat velocities in the elderly measured by continuous wave Doppler. Am Heart J, 1989,117:1320-1326.
  • 9Chikamori T, Doi YL, Ynoezawa Y, et al. Comparison of clinical features in patients≥60 years of age to those ≤40 years of age with hypertrophic cardiomyopathy. Am J Cardiol, 1990,66: 875-878.

二级参考文献10

  • 1黄德嘉.心脏性猝死的预防——2002美国心脏学会、美国心脏病学会和北美心脏起搏与心电生理学会指南导读[J].中华心血管病杂志,2004,32(10):925-927. 被引量:6
  • 2ACC/ESC EXPERT CONSENSUS DOCUMENT. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol, 2003,42:1687-1713; European Heart Journal, 2003,24:1965-1991.
  • 3AHA Scientific Statement. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation, 2004,109:2807-2816.
  • 4Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force3 on the Definition and Classification of Cardiomyopathies. Circulation, 1996,93:841-842.
  • 5Maron BJ. Hypertrophic cardiomyopathy in childhood. Pediatr Clin N Am, 2004,51:1305-1346.
  • 6Elliott P, Mckenna WJ. Hypertrophic cardiomyopathy. Lancent, 2004,363: 1881-1891.
  • 7Hughes SE, McKenna WJ. New insight into the pathology of inherited cardiomyopathy. Heart, 2005,91:257-264.
  • 8Doolan A,Tebo M,Semsarian C, et al. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences. J Mol Cell Cardiol, 2005,38: 387-393.
  • 9Yetman AT, McCrindle BW. Management of pediatric hypertrophic cardiomyopathy. Curr Opin Cardiol,2005,20:80-83.
  • 10Camm AJ. Should we afford implantable cardioverter defibrillator therapy. Nature Clinical Practice Cardiovascular Medicine, 2005,2:59.

共引文献34

同被引文献45

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部